June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Assessment the long term effect of corneal cross-linking therapy on corneal ectasia in progressive keratoconus
Author Affiliations & Notes
  • Illes Kovacs
    Department of Ophthalmology, Semmelweis University, Budapest, Hungary
  • Kinga Kranitz
    Department of Ophthalmology, Semmelweis University, Budapest, Hungary
  • Andrea Gyenes
    Department of Ophthalmology, Semmelweis University, Budapest, Hungary
  • Gábor László Sándor
    Department of Ophthalmology, Semmelweis University, Budapest, Hungary
  • Eva Juhasz
    Department of Ophthalmology, Semmelweis University, Budapest, Hungary
  • Lorant Dienes
    Department of Ophthalmology, Semmelweis University, Budapest, Hungary
  • Janos Nemeth
    Department of Ophthalmology, Semmelweis University, Budapest, Hungary
  • Zoltan Nagy
    Department of Ophthalmology, Semmelweis University, Budapest, Hungary
  • Footnotes
    Commercial Relationships Illes Kovacs, None; Kinga Kranitz, None; Andrea Gyenes, None; Gábor László Sándor, None; Eva Juhasz, None; Lorant Dienes, None; Janos Nemeth, None; Zoltan Nagy, Alcon-LenSx Inc. (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5275. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Illes Kovacs, Kinga Kranitz, Andrea Gyenes, Gábor László Sándor, Eva Juhasz, Lorant Dienes, Janos Nemeth, Zoltan Nagy, ; Assessment the long term effect of corneal cross-linking therapy on corneal ectasia in progressive keratoconus. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5275.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate stabilizing effect of cross-linking (CXL) therapy on corneal ectasia in progressive keratoconus with Scheimpflug imaging.

Methods: In this prospective study corneal CXL was performed in 22 progressive keratoconus eyes (CXL group) and 28 clinically non-progressive keratoconus eyes served as controls (control group). Anterior keratometry readings at the steepest meridian (Ks), thinnest corneal thickness (ThCT) and posterior elevation values at the thinnest point of the cornea (PE) were measured using Scheimpflug-camera at baseline and 12-25 months after enrolment. Cox proportional regression model was used to evaluate long term effect of CXL on keratoconus progression taken into account the within-subject fluctuations of measurements.

Results: At baseline, higher Ks (CXL: 49.87±3.62 D vs. control: 46.76±3.25 D; p=0.002), higher PE (CXL: 27.05±17.13 µm vs. control: 14.36±12.54 µm; p=.006) and lower ThCT values (CXL: 461.52±24.43 µm vs. control: 497.64±31.68 µm; p<0.001) showed more advanced keratoconus cases in the CXL group compared to controls. During the follow up, there was no significant change in mean keratometry values compared to baseline in the CXL group (48.51 ± 3.64 D; p>0.05) and only 2 of 22 cases showed progression in keratometry values beyond within-subject fluctuation. In the control group marginally significant increase was measured in mean keratometry (46.90 ± 3.33 D; p=0.06) and keratometry values increased beyond within-subject fluctuation in 11 of 28 cases. The Cox model showed, that after CXL treatment the ratio of further keratometry progression was 0.09 (95% CL: 0.02 - 0.57; p=0.01) compared to controls after adjustment for initial ThCT.

Conclusions: CXL decreased the incidence of progression in advanced keratoconus by 91% after a long term follow-up independently from initial corneal pachymetry. Steep keratometry is a sensitive parameter to monitor stabilizing effect of corneal cross-linking therapy.

Keywords: 574 keratoconus • 479 cornea: clinical science  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×